September 28, 2020

Richard Becker, MD, and Duncan Hite, MD, both professors in the UC College of Medicine and UC Health physicians, spoke with WVXU reporter Ann Thompson about a phase 2 clinical trial underway at UC/UC Health to determine the safety and efficacy of the drug razuprotafib in treating COVID-19 patients. UC is one of 20 sites across the nation participating in the trial.

September 30, 2020

Drug Target Review discusses findings of a study looking at the use of a naturally occurring lipid to prevent COVID-19 infection.

September 29, 2020

About 34 million Americans are diagnosed with diabetes. It is the seventh leading cause of death in our nation. Individuals with uncontrolled diabetes are among the groups most at risk of experiencing severe reactions to COVID-19. The pandemic has forced businesses to close or lay off employees impacting the ability of families to make their incomes cover housing, food and medicine. How can families continue to make healthy options when some are limited to shopping at a nearby dollar store?

October 14, 2020

Michael Thomas, MD, professor and chair of the UC Department of Obstetrics and Gynecology and UC Health physician, spoke with STAT about barriers black women face in obtaining fertility services. Studies suggest that black women might be twice as likely as white women to have fertility problems but far less likely to receive infertility treatment.

September 30, 2020

Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed by a reporter for Contagion Live about a new phase 2 clinical trial UC and UC Health are conducting using the drug razuprotafib, to lessen inflammation of the blood vessels in COVID-19 patients. Razuprotafib activates a key pathway for stabilizing blood vessels in the lungs and may prevent or treat respiratory distress in COVID-19 patients.

November 12, 2020

A UC expert discusses a new study from the University of Oxford that shows around 20% of COVID-19 survivors are struggling with mental health issues after recovering from the disease.

November 9, 2020

Dr. Katie Burns, an assistant professor at the University of Cincinnati, discusses her battle with endometriosis, up close and personal and inside the lab. She is seeking a better treatment and hopefully a cure to a condition that affects one in 10 women.

November 20, 2020

UC researchers treated their first study patient this week using a new cancer therapy that takes less than one second. This clinical trial is being hosted at the Cincinnati Children's/UC Health Proton Therapy Center.

November 18, 2020

Carl Fichtenbaum, MD, was interviewed by several media outlets including WLWT-TV, after Moderna reported 95% efficacy in preliminary analysis of its COVID-19 trial. Fichtenbaum is the co-investigator of the trial of the vaccine at UC.

November 17, 2020

Richard Becker, MD, director of the University of Cincinnati Heart, Lung and Vascular Institute, also weighed in on a research finding out of Spain. The observational study of 9,000 elderly patients on oral anticoagulants suggests bleeding thought related to antithrombotic therapy may be an early warning sign for as-yet-undetected cancer.